<?xml version="1.0" encoding="UTF-8"?>
<p id="P28">Ganciclovir is an acyclic 2â€²-deoxyguanosine analogue for the management of CMV.
 <sup>
  <xref ref-type="bibr" rid="R65">65</xref>
 </sup> It is available in oral and parenteral formulations. Oral ganciclovir is poorly absorbed, with a bioavailability of only 5%.
 <sup>
  <xref ref-type="bibr" rid="R65">65</xref>
 </sup> Management of active CMV disease is therefore with IV ganciclovir or its oral valyl prodrug valganciclovir. Intravitreal ganciclovir implants are also available, with minimal systemic absorption. Ganciclovir is excreted renally.
</p>
